Relay Therapeutics RLAY
NASDAQ RLAY
$17.98 -0.38 (-2.07%)
As of: Sep 30, 2026 · 1:32 PM EDT

Relay Therapeutics, Inc. (RLAY) Operating Income (2019 - 2026)

Updated

Relay Therapeutics (RLAY) reported Operating Income of -$90.82 million for Q2 2026, compared with -$76.85 million a year earlier.

Analysis

Relay Therapeutics, Inc. (RLAY) Operating Income (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Relay Therapeutics' Operating Income came in at -$310.44 million; for FY2025, it came in at -$302.74 million.

  • By year, Operating Income came in at -$372.47 million in FY2024, -$373 million in FY2023, -$299.28 million in FY2022 and -$364.7 million in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Operating Income since Q3 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$78.59 million (Q1 2026), -$60.63 million (Q4 2025) and -$80.39 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -90.82 Mn
Mar 31, 2026 -78.59 Mn
Dec 31, 2025 -60.63 Mn
Sep 30, 2025 -80.39 Mn
Jun 30, 2025 -76.85 Mn
Mar 31, 2025 -84.87 Mn
Dec 31, 2024 -84.98 Mn
Sep 30, 2024 -96.37 Mn
Jun 30, 2024 -100.76 Mn
Mar 31, 2024 -90.36 Mn
Dec 31, 2023 -92.20 Mn
Sep 30, 2023 -73.58 Mn
Jun 30, 2023 -106.05 Mn
Mar 31, 2023 -101.18 Mn
Dec 31, 2022 -72.85 Mn
Sep 30, 2022 -85.89 Mn
Jun 30, 2022 -77.81 Mn
Mar 31, 2022 -62.72 Mn
Dec 31, 2021 -67.72 Mn
Sep 30, 2021 -60.99 Mn
API Access

Relay Therapeutics, Inc. Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=RLAY&period=max&api_key=YOUR_API_KEY